ASCO-GU

ASCO-GU – Bicycle tries to put distance between itself and Seagen
EP Vantage
Thu, 02/16/23 - 10:15 am
ASCO-GU
Bicycle Therapeutics
Seagen
Padcev
urothelial cancer
BT8009
ASCO-GU – prostate cancer PARPS move to the front line
EP Vantage
Sun, 02/20/22 - 11:44 am
prostate cancer
ASCO-GU
PARP inhibitors
Lynparza
Zejula
Rubraca
Talzenna
biomarkers
AstraZeneca
Merck
GSK
JNJ
Clovis Oncology
ASCO-GU – Arvinas sees the path to a prostate cancer niche
EP Vantage
Wed, 02/16/22 - 10:26 am
Arvinas
ARV-110
prostate cancer
ASCO-GU
Asco-GU – confirmatory Padcev trial throws a curveball
EP Vantage
Fri, 02/12/21 - 10:59 am
Astellas
Seagen
Padcev
bladder cancer
ASCO-GU